Jung Kai Shao
Corporate Officer/Principal bei TaiGen Biotechnology Co., Ltd.
Profil
Jung Kai Shao is a professional with experience in business development.
He is currently working as Vice President-Business Development at TaiGen Biotechnology Co., Ltd.
He has previously worked as Senior Director-Business Development at Repros Therapeutics, Inc., Director-Business Development at Mitsubishi Tanabe Pharma Corp., and Senior Vice President-Business Development at TaiGen Biopharmaceuticals Holdings Ltd.
He holds an MBA from Temple University and completed his undergraduate and doctorate degrees from the University of Toronto.
Aktive Positionen von Jung Kai Shao
| Unternehmen | Position | Beginn |
|---|---|---|
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Corporate Officer/Principal | 03.10.2011 |
Ehemalige bekannte Positionen von Jung Kai Shao
| Unternehmen | Position | Ende |
|---|---|---|
| TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Corporate Officer/Principal | 07.04.2019 |
| MITSUBISHI TANABE PHARMA CORPORATION | Corporate Officer/Principal | - |
| REPROS THERAPEUTICS INC | Corporate Officer/Principal | - |
Ausbildung von Jung Kai Shao
| University of Toronto | Doctorate Degree |
| Temple University (Pennsylvania) | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
